Please use this identifier to cite or link to this item:
http://bibliotecadigital.economia.gov.br/handle/123456789/527814
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor | Meirelles, Beatriz Barbosa | - |
dc.contributor | Pimentel, Vitor Paiva | - |
dc.contributor | Cruz, Adriana Inhudes Gonçalves da | - |
dc.contributor | Reis, Carla | - |
dc.contributor | Banco Nacional de Desenvolvimento Econômico e Social (Brasil). Gabinete da Presidência. Departamento de Divulgação. Gerência de Editoração | - |
dc.date.accessioned | 2020-07-30T18:06:35Z | - |
dc.date.accessioned | 2022-05-12T03:57:12Z | - |
dc.date.available | 2020-07-30T18:06:35Z | - |
dc.date.available | 2022-05-12T03:57:12Z | - |
dc.date.created | 2020-07-30T18:06:35Z | - |
dc.date.issued | 2020-03 | - |
dc.identifier | MEIRELLES, Beatriz Barbosa et al. Balanço da estratégia de desenvolvimento da biotecnologia farmacêutica no Brasil: 2009-2019 = Pharmaceutical biotechnology industrial development: an assessment of Brazil’s strategy from 2009 to 2019. BNDES Setorial, Rio de Janeiro, v. 26, n. 51, p. 7-75, mar. 2020. | - |
dc.identifier | http://web.bndes.gov.br/bib/jspui/handle/1408/19802 | - |
dc.identifier.uri | http://bibliotecadigital.economia.gov.br/handle/123456789/527814 | - |
dc.description.abstract | Pharmaceutical biotechnology has created opportunities for the treatment of rare and complex diseases, and has become strategic for innovation policies worldwide, including Brazil. The Brazilian scientific vocation for molecular biology and genomics gave rise to several public policies to internalize specific productive capacity and advance the development of innovative products. The gradual incorporation of those drugs in the Unified Health System (SUS) reinforced the need to spread the use of biosimilars and internalize their production; thus, guaranteeing a stable offer at competitive prices. BNDES contributed to the formulation and application of these policies by financing productive plants and product development; BNDES also participated in collegiate bodies and published articles since 2009. This study aims to analyze the Bank's evolution, focusing on the following axes: public procurement, financing, and regulation. | - |
dc.language | pt_BR | - |
dc.publisher | Banco Nacional de Desenvolvimento Econômico e Social | - |
dc.relation | http://web.bndes.gov.br/bib/jspui/handle/1408/19801 | - |
dc.subject | Banco Nacional de Desenvolvimento Econômico e Social (Brasil) - Financiamento | - |
dc.subject | Brazilian Development Bank - Financing | - |
dc.subject | FINEP | - |
dc.subject | BNDES Funtec | - |
dc.subject | BNDES Profarma | - |
dc.subject | BNDES Support Program to Develop the Industrial Health Sector | - |
dc.subject | Sistema Único de Saúde (Brasil) | - |
dc.subject | Sistema Único de Saúde (Brazil) | - |
dc.subject | Indústria farmacêutica - Brasil - 2009-2019 | - |
dc.subject | Pharmaceutical industry - Brazil - 2009-2019 | - |
dc.subject | Biotecnologia farmacêutica - Brasil - 2009-2019 | - |
dc.subject | Pharmaceutical biotechnology - 2009-2019 | - |
dc.subject | Política industrial - Brasil - 2004-2014 | - |
dc.subject | Industrial policy - Brazil - 2004-2014 | - |
dc.subject | Saúde | - |
dc.subject | Health | - |
dc.subject | Política pública | - |
dc.subject | Public policy | - |
dc.subject | Inovação | - |
dc.subject | Innovation | - |
dc.subject | Pesquisa e desenvolvimento | - |
dc.subject | Research and development | - |
dc.title | Balanço da estratégia de desenvolvimento da biotecnologia farmacêutica no Brasil: 2009-2019 | - |
dc.type | Artigo | - |
Appears in Collections: | Produção BNDES - Artigos |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.